KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business OfficerRead More
Ghislaine joined Selexis in July 2015 as Genomic Director responsible for the microscopy characterization of Selexis Research Cell Banks (RCBs). In this role, she has developed a microscopy platform for transgene insertion site mapping using DNA-Fluorescence In-Situ Hybridization (FISH). She is also evaluating new technologies in Selexis’ cell line development process.
She studied biochemistry at the University of Montpellier and obtained her MSc. in molecular and cellular pharmacology at the University Paul Sabatier of Toulouse, France. Ghislaine earned her PhD in molecular biology in Geneva in the laboratory of Prof. Laemmli, where she discovered a new role for nuclear pore complexes in chromatin partitioning. This led to a publication in Cell. During her post-doctorate work at EMBL (European Molecular Biology laboratories) in Germany, she studied relations between gene expression and gene nuclear position using microscopy.
Ghislaine’s work has been published in a number of peer-reviewed journals. During her time at EMBL, she was awarded a Humboldt Fellowship.